These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27310932)

  • 1. Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
    Mameli G; Arru G; Caggiu E; Niegowska M; Leoni S; Madeddu G; Babudieri S; Sechi GP; Sechi LA
    PLoS One; 2016; 11(6):e0157153. PubMed ID: 27310932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-126: a novel route for natalizumab action?
    Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL
    Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of viral and self-antigens by T
    Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
    J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
    Arru G; Caggiu E; Leoni S; Mameli G; Pugliatti M; Sechi GP; Sechi LA
    J Neurol Sci; 2015 Oct; 357(1-2):106-8. PubMed ID: 26190523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
    Castellazzi M; Delbue S; Elia F; Gastaldi M; Franciotta D; Rizzo R; Bellini T; Bergamaschi R; Granieri E; Fainardi E
    Dis Markers; 2015; 2015():901312. PubMed ID: 26101453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-26a modulates inflammatory response induced by toll-like receptor 4 stimulation in microglia.
    Kumar A; Bhatia HS; de Oliveira AC; Fiebich BL
    J Neurochem; 2015 Dec; 135(6):1189-202. PubMed ID: 26376347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
    PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
    Muñoz-Culla M; Irizar H; Castillo-Triviño T; Sáenz-Cuesta M; Sepúlveda L; Lopetegi I; López de Munain A; Olascoaga J; Baranzini SE; Otaegui D
    Mult Scler; 2014 Dec; 20(14):1851-9. PubMed ID: 24852919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis.
    Potenza N; Mosca N; Mondola P; Damiano S; Russo A; De Felice B
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):317-323. PubMed ID: 28962897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis.
    Zhou Y; Chen M; Simpson S; Lucas RM; Charlesworth JC; Blackburn N; van der Mei I; Ponsonby AL; ; Taylor BV
    Neurol Sci; 2018 Feb; 39(2):297-304. PubMed ID: 29127522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population.
    Li Y; Du C; Wang W; Ma G; Cui L; Zhou H; Tao H; Yao L; Zhao B; Li K
    Cell Physiol Biochem; 2015; 35(1):281-91. PubMed ID: 25591770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a negatively regulates the induction of proinflammatory cytokines in response to Japanese encephalitis virus infection in microglial cells.
    Deng M; Du G; Zhao J; Du X
    Arch Virol; 2017 Jun; 162(6):1495-1505. PubMed ID: 28190197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
    Yang L; Zhang X; Peng W; Wei M; Qin W
    Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2).
    Wu R; He Q; Chen H; Xu M; Zhao N; Xiao Y; Tu QQ; Zhang W; Bi X
    Biochem Biophys Res Commun; 2017 May; 486(3):759-766. PubMed ID: 28342869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.